CurrentBlue Cross Blue Shield - WisconsinPolicy 01-102

Interim Caries Arresting Medicament Application Guidelines

Guidance governing use of topical interim caries-arresting medicaments (for example, silver diamine fluoride) as a conservative treatment for active, non‑symptomatic carious lesions; intended for dentists and utilization reviewers assessing medical/dental necessity and coverage under the plan.

Policy Summary

PayerBlue Cross Blue Shield - Wisconsin

PolicyInterim Caries Arresting Medicament Application Guidelines

Policy CodePolicy 01-102

Change TypeNo material changes

Effective Date

Next Review Date

Key ActionDocument that application was for active, non‑symptomatic carious lesions and that the patient was unable to undergo standard restorative treatment or that application otherwise meets the coverage criteria.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

6Indication points

D1354, D1355, D1206...Example CDT codes

2021-10-06Last review

Coverage Criteria

Coverage criteria for interim caries arresting medicament

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Primary indication: Application is used only as a conservative treatment for active, non‑symptomatic carious lesions

Supported by definition of treatment

Patient or treatment context: Patient is unable to withstand standard restorative treatment (frail, uncooperative children, physical and/or cognitive disabilities) OR has numerous lesions that cannot be treated in one visit OR has caries difficult to treat with traditional restorations OR has limited access to dental care OR when traditional hand piece is not available

Any one of these contexts makes application appropriate

Coverage for interim caries arresting medicament application is provided only when the service is used as a conservative, non‑restorative treatment for active, non‑symptomatic carious lesions and all coverage criteria are met. The application is intended as a topical, non‑mechanical approach without removal of sound tooth structure and is appropriate when traditional restorative treatment is not feasible for the patient (for example, frailty, uncooperative children, or significant physical/cognitive disability), when a patient has numerous lesions that cannot be completed in a single visit, when lesions are difficult to treat with traditional restorations, when access to dental care is limited, or when the traditional dental handpiece is not available.

Documentation supporting coverage must confirm the lesion was active but non‑symptomatic and describe the patient or treatment context that precludes standard restorative care (for example, behavioral or medical limitations, extent of disease, or access constraints). Plans or specific lines of business may apply utilization review or prior authorization per contract; contact customer service to determine whether review is required for a member.

The application is not intended for treatment of symptomatic lesions or as a substitute where traditional restorative treatment is appropriate and feasible. Services that are primarily cosmetic, performed for patient or dentist convenience, or not consistent with generally accepted standards of dental practice are not considered medically or dentally necessary for coverage determinations and may be excluded.

The plan evaluates dental services against generally accepted standards of care — treatments should be provided by a dentist exercising prudent clinical judgment, be effective in type, frequency and extent for the patient’s condition, and not be more costly than appropriate alternatives. A determination that a service is clinically appropriate does not guarantee it is a covered benefit under a member’s contract.

Coding and Billing

CDT codes referencedCDT

D1206	Topical application of fluoride varnish
D1208	Topical application of fluoride - excluding varnish
D1352	Preventive resin restoration in a moderate to high caries risk patient - permanent tooth
D1354	Application of caries arresting medicament - per tooth
D1355	Caries preventive medicament application - per tooth
D2941	Interim therapeutic restoration - primary dentition

Provider Actions & Documentation

Prior Authorization

Prior Authorization Requirement

Prior authorization may be required at the plan's discretion. Contact the customer's service number on the member's ID card to determine whether prior authorization or utilization review is required for interim caries arresting medicament application (for example, silver diamine fluoride).

Check member-specific contract/plan rules for prior authorization requirements.

Documentation Required

Provider Documentation Requirements

Document the indication for treatment and the clinical findings that support use of an interim caries arresting medicament. Include tooth/lesion location, lesion activity (active vs. arrested), presence or absence of symptoms, and rationale for choosing a non‑restorative approach over definitive mechanical treatment.

Record tooth/lesion identifier and clinical description (e.g., cavitated vs non‑cavitated, active).
Note patient's symptoms: must be non‑symptomatic to meet the interim caries definition.
Provide justification if definitive restorative treatment (e.g., removal of tooth structure) could not be performed or was contraindicated.

Documentation Required

Documentation: Support for Indication and Inability to Undergo Definitive Treatment

Documentation should specifically support that the application was for an active, non‑symptomatic carious lesion and that definitive treatment was not appropriate or could not be performed. Records should show clinical judgment consistent with generally accepted standards of dental practice and that the service was not primarily for convenience or cosmetic purposes.

Evidence that the lesion was active and non‑symptomatic.
Clinical rationale for conservative management (e.g., medical contraindication, behavioral limitations, or interim palliative need).
Notes demonstrating treatment choice aligns with generally accepted standards of dental care.

Denial Risk

Services that do not meet accepted standards of dental care or plan contractual benefit provisions may be denied. The fact a treatment is clinically described here does not guarantee coverage; plan contract terms determine payable benefits.

Claims may be denied if documentation does not demonstrate active, non‑symptomatic lesion or inability to perform definitive treatment.
Coverage is subject to member's contract and plan-specific adoption of the guideline.

Background

Interim caries arresting medicament application is a conservative, topical treatment applied to active, non‑symptomatic carious lesions without mechanical removal of sound tooth structure. A commonly used agent is silver diamine fluoride (SDF). The approach is intended to arrest or inhibit caries progression when traditional restorative approaches are impractical or inappropriate for the patient.

This guideline aligns utilization review with generally accepted standards of dental practice: the medicament application is an adjunctive, non‑restorative therapy used when clinical circumstances (behavioral, medical, logistical, or extent of disease) make standard restorative care unsuitable or infeasible.

Definitions

Interim caries arresting medicament application — definition and key attributes

DefinitionConservative treatment of an active, non‑symptomatic carious lesion by topical application of a caries‑arresting or inhibiting medicament without mechanical removal of sound tooth structure.

Typical agent exampleSilver diamine fluoride (SDF) is a commonly used caries‑arresting medicament.

Intended indicationUsed only for active, non‑symptomatic carious lesions — not for symptomatic lesions or routine restorative care.

Treatment approachTopical application only; does not involve mechanical removal of sound tooth structure.

Standard of care requirementApplication must align with generally accepted standards of dental practice and be provided using prudent clinical judgment.